The regulation of human factor XIIa by plasma proteinase inhibitors.

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT

1951 • 319,299 citations

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1970 • 253,849 citations

Immunochemical quantitation of antigens by single radial immunodiffusion

1965 • 9,369 citations

The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Application to the radioimmunoassay

1973 • 3,279 citations

Catalysis in chemistry and enzymology

1969 • 3,236 citations

Esters of Methanesulfonic Acid as Irreversible Inhibitors of Acetylcholinesterase

1962 • 1,510 citations

[2] Titration of trypsin, plasmin, and thrombin with p-nitrophenyl p′-guanidinobenzoate HCl

1970 • 497 citations

IN VIVO BEHAVIOR OF I131-FIBRINOGEN

1963 • 469 citations

A FAMILIAL HEMORRHAGIC TRAIT ASSOCIATED WITH A DEFICIENCY OF A CLOT-PROMOTING FRACTION OF PLASMA 1

1955 • 454 citations

Hemostasis and Thrombosis, Basic Principles and Clinical Practice

1983 • 450 citations

Determination of α2-macroglobulin as trypsin-protein esterase

1966 • 372 citations

STUDIES ON HUMAN PLASMA α2-MACROGLOBULIN-ENZYME INTERACTIONS

1973 • 362 citations

Isolation and characterization of a human plasma protein with affinity for the lysine binding sites in plasminogen. Role in the regulation of fibrinolysis and identification as histidine-rich glycoprotein.

1980 • 289 citations

Autoactivation of human Hageman factor. Demonstration utilizing a synthetic substrate.

1980 • 229 citations

Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator.

1970 • 224 citations

Activation of plasminogen by human plasma kallikrein

1969 • 219 citations

Contribution of Plasma Protease Inhibitors to the Inactivation of Kallikrein in Plasma

1982 • 218 citations

Inhibition by CaINH of Hageman Factor Fragment Activation of Coagulation, Fibrinolysis, and Kinin Generation

1973 • 211 citations

Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis.

1977 • 210 citations

Structural characterization of human alpha2-macroglobulin subunits.

1979 • 207 citations

Prekallikrein Activation and High-Molecular-Weight Kininogen Consumption in Hereditary Angioedema

1983 • 204 citations

Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of “spontaneous” formation of bradykinin

1983 • 200 citations

Inhibition of activated factor XII by antithrombin-heparin cofactor.

1976 • 200 citations

Mechanisms of activation of the classical pathway of complement by Hageman factor fragment.

1983 • 196 citations

Activation of human factor XI (plasma thromboplastin antecedent) by factor XIIa (activated Hageman factor)

1977 • 189 citations

Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor.

1984 • 180 citations

Hageman factor fragment inhibitor in corn seeds: Purification and characterization

1980 • 168 citations

Characterization of human, bovine, and horse antithrombin III

1976 • 168 citations

Structural Changes Accompanying Enzymatic Activation of Human Hageman Factor

1974 • 152 citations

Activation of bovine factor VII by hageman factor fragments

1977 • 150 citations

MECHANISMS OF ACTIVATION OF C'1 ESTERASE IN HEREDITARY ANGIONEUROTIC EDEMA PLASMA IN VITRO

1968 • 142 citations

A rapid method for removal of [125I]iodide following iodination of protein solutions

1980 • 138 citations

Detection of active kallikrein in induced blister fluids of hereditary angioedema patients.

1980 • 135 citations

Affinity-chromatographic purification of human α2-antiplasmin

1980 • 132 citations

The cleavage and formation of activated human Hageman factor by autodigestion and by kallikrein.

1982 • 124 citations

Measurement of Alpha1-Antitrypsin in Serum, by Immunodiffusion and by Enzymatic Assay

1974 • 108 citations

Ein Beitrag zur Isolierung und Charakterisierung des C‐Inaktivators aus Humanplasma

1970 • 104 citations

Enzymatic activities of activated and zymogen forms of human Hageman factor (factor XII)

1982 • 85 citations

High molecular weight kininogen or its light chain protects human plasma kallikrein from inactivation by plasma protease inhibitors

1982 • 75 citations

Enzymatic activities of activated and zymogen forms of human Hageman factor (factor XII)

1982 • 70 citations

Interaction of α2-macroglobulin with trypsin, chymotrypsin, plasmin, and papain

1983 • 69 citations

Radioimmunoassay of human Hageman factor (factor XII).

1976 • 69 citations

Characterization of functional human .alpha.2-macroglobulin half-molecules isolated by limited reduction with dithiothreitol

1983 • 68 citations

[16] Human factor XII (hageman factor)

1981 • 64 citations

Localization of the two protease binding sites in human alpha 2-macroglobulin.

1981 • 59 citations

[5] Preparation and properties of human inhibitor

1981 • 58 citations

Studies of C1 inactivator-plasma kallikrein complexes in purified systems and in plasma.

1983 • 55 citations

Inhibitory spectrum of alpha 2-plasmin inhibitor.

1979 • 52 citations

Inhibition of proteases by alpha 2-macroglobulin. The role of lysyl amino groups of trypsin in covalent complex formation.

1981 • 48 citations

Size and shape of human CI‐inhibitor

1981 • 41 citations

The binding of bovine factor XII to kaolin

1983 • 40 citations

The inhibition of activated factor XII (hageman factor) by antithrombin III: The effect of other plasma proteinase inhibitors

1977 • 40 citations

New and rapid functional assay for C1 inhibitor in human plasma

1982 • 29 citations

A two‐step purification procedure for α₂‐macroglobulin based on pseudo‐ligand affinity chromatography

1982 • 24 citations

Inhibition of activated haceman factor (factor XIIa) by an inhibitor of the plasminogen activation (PA inhibitor)

1978 • 22 citations

Effect of heparin on the inhibition of thrombin by α1-proteinase inhibitor

1979 • 18 citations

The evolution of clot-promoting and amidolytic activities in mixtures of Hageman factor (factor XII) and ellagic acid.

1982 • 13 citations